{"id":"fludarabin","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Neutropenia","drugRate":"59%","severity":"common","organSystem":""},{"effect":"Anemia","drugRate":"60%","severity":"common","organSystem":""},{"effect":"Thrombocytopenia","drugRate":"55%","severity":"common","organSystem":""},{"effect":"Pneumonia","drugRate":"22%","severity":"common","organSystem":""},{"effect":"Infection","drugRate":"","severity":"common","organSystem":""},{"effect":"Fever and chills","drugRate":"","severity":"common","organSystem":""},{"effect":"Nausea and vomiting","drugRate":"","severity":"common","organSystem":""},{"effect":"Malaise","drugRate":"","severity":"common","organSystem":""},{"effect":"Fatigue","drugRate":"","severity":"common","organSystem":""},{"effect":"Anorexia","drugRate":"","severity":"common","organSystem":""},{"effect":"Weakness","drugRate":"","severity":"common","organSystem":""},{"effect":"Edema","drugRate":"","severity":"common","organSystem":""},{"effect":"Diarrhea","drugRate":"","severity":"common","organSystem":""},{"effect":"Skin rashes","drugRate":"","severity":"common","organSystem":""},{"effect":"Stomatitis","drugRate":"","severity":"common","organSystem":""}],"contraindications":["Acquired factor VIII deficiency disease","Acquired hemolytic anemia","Acute infectious disease","Acute nephropathy","Anemia","Autoimmune hemolytic anemia","Autoimmune thrombocytopenia","Bacterial infectious disease","Bone marrow depression","Breastfeeding (mother)","CNS Toxicity","Chemotherapy-Induced Hyperuricemia","Coma","Conduction disorder of the heart","Decompensated cardiac failure","Disorder of optic nerve","Edema","Evans syndrome","Extrinsic allergic alveolitis","Feeling agitated","Herpes zoster","Idiopathic thrombocytopenic purpura","Impaired cognition","Impaired renal function disorder","Interstitial pneumonia","Liver function tests abnormal","Mycosis","Neutropenic disorder","Optic neuritis","Pancytopenia","Pregnancy, function","Progressive multifocal leukoencephalopathy","Seizure disorder","Uric acid renal calculus","Visual impairment"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Autoimmune hemolytic anemia","drugRate":"","severity":"serious"},{"effect":"Tumor lysis syndrome","drugRate":"","severity":"serious"},{"effect":"Bone marrow fibrosis","drugRate":"","severity":"serious"},{"effect":"Trilineage bone marrow hypoplasia/aplasia","drugRate":"","severity":"serious"},{"effect":"Pancytopenia","drugRate":"","severity":"serious"},{"effect":"Pulmonary toxicity/ARDS","drugRate":"","severity":"serious"},{"effect":"Pulmonary hemorrhage","drugRate":"","severity":"serious"},{"effect":"Pulmonary fibrosis","drugRate":"","severity":"serious"},{"effect":"Hemorrhagic cystitis","drugRate":"","severity":"serious"},{"effect":"Pericardial effusion","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":{"chemblId":"CHEMBL1096882","moleculeType":"Small molecule","molecularWeight":"365.21"},"aliases":["FLUDARA®"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"cf5255cc-91fd-4132-973b-764dba142eae","title":"FLUDARABINE (FLUDARABINE PHOSPHATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]"},"ecosystem":[],"mechanism":{"target":"Carbonic anhydrase 5A, mitochondrial, DNA polymerase alpha catalytic subunit, Ribonucleoside-diphosphate reductase large subunit"},"_scrapedAt":"2026-03-28T04:00:18.966Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Acute myeloid leukemia, disease","diseaseId":"acute-myeloid-leukemia-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chronic lymphoid leukemia, disease","diseaseId":"chronic-lymphoid-leukemia-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Low-grade B cell non-Hodgkin lymphoma","diseaseId":"low-grade-b-cell-non-hodgkin-lymphoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Mantle cell lymphoma","diseaseId":"mantle-cell-lymphoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06649227","phase":"PHASE1","title":"Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19","status":"RECRUITING","sponsor":"University Hospital, Lille","startDate":"2025-07-10","conditions":"Relapsed Adult AML","enrollment":5},{"nctId":"NCT05296564","phase":"PHASE1, PHASE2","title":"Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers","status":"RECRUITING","sponsor":"Hadassah Medical Organization","startDate":"2022-04-01","conditions":"Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV","enrollment":3},{"nctId":"NCT03919240","phase":"PHASE1, PHASE2","title":"CAR-T Cell Therapy Targeting to CD19 for R/R ALL","status":"ACTIVE_NOT_RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2015-12-01","conditions":"Acute Lymphoblastic Leukemia with Failed Remission","enrollment":196},{"nctId":"NCT02623309","phase":"PHASE3","title":"Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients","status":"COMPLETED","sponsor":"Institut Paoli-Calmettes","startDate":"2016-02-23","conditions":"Hematologic Neoplasms","enrollment":108},{"nctId":"NCT04000698","phase":"PHASE3","title":"Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias","status":"UNKNOWN","sponsor":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","startDate":"2019-10-15","conditions":"Refractory Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia","enrollment":25},{"nctId":"NCT00785330","phase":"PHASE2","title":"Allo-hNHL (FluBuCy)","status":"COMPLETED","sponsor":"Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH","startDate":"2004-04","conditions":"Non-Hodgkin's Lymphoma","enrollment":84},{"nctId":"NCT01786018","phase":"PHASE2","title":"Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas","status":"UNKNOWN","sponsor":"Azienda Ospedaliera San Giovanni Battista","startDate":"2013-02","conditions":"B-cell Lymphoma Refractory","enrollment":42},{"nctId":"NCT01455506","phase":"PHASE1","title":"PRO#0118: Decitabine Plus Mini Flu-Bu","status":"COMPLETED","sponsor":"Hackensack Meridian Health","startDate":"2009-05","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndrome","enrollment":20},{"nctId":"NCT01849939","phase":"PHASE2","title":"Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia","status":"UNKNOWN","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2012-09","conditions":"Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma","enrollment":43},{"nctId":"NCT00750126","phase":"PHASE2","title":"Allogeneic Hematopoietic Stem Cell Transplantation","status":"UNKNOWN","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2007-04","conditions":"Solid Tumors, Hematologic Neoplasms","enrollment":30}],"_emaApprovals":[],"_faersSignals":[{"count":18,"reaction":"CYTOMEGALOVIRUS INFECTION"},{"count":17,"reaction":"OFF LABEL USE"},{"count":16,"reaction":"PYREXIA"},{"count":12,"reaction":"FEBRILE NEUTROPENIA"},{"count":10,"reaction":"DRUG INEFFECTIVE"},{"count":9,"reaction":"EPSTEIN-BARR VIRUS INFECTION"},{"count":9,"reaction":"GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT"},{"count":9,"reaction":"PNEUMONIA"},{"count":8,"reaction":"ADENOVIRUS INFECTION"},{"count":8,"reaction":"BLOOD BILIRUBIN INCREASED"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":57,"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Fludarabin","genericName":"Fludarabin","companyName":"Azienda Ospedaliera San Giovanni Battista","companyId":"azienda-ospedaliera-san-giovanni-battista","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}